Key facts
- Kinspire’s last known valuation is $7.7M (Jan 2023).
- It has raised $3.4M across 2 recorded rounds; the latest was Seed Round ($2.2M) in Aug 2022.
- Notable investors include Everywhere Ventures, Service Provider Capital, Great Oaks Venture Capital, Pave Health Ventures, Bradley Tusk — 11 tracked in total.
- Kinspire has filed 2 Form Ds with the SEC since 2021, most recently Aug 2022 ($2.2M sold to 16 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Kinspire
Funding rounds
2 roundsAbout Kinspire
Provider of developmental therapy services intended to enhance children's growth and support family well-being. The company offers continuous access to licensed therapists and features personalized care plans, a play-based approach with individualized strategies, enabling families to receive tailored support anytime and anywhere, promoting effective developmental progress.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2020
- Employees
- 19
- Website
- kinspirehealth.com/
- Ownership
- Privately Held (backing)
Kinspire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kinspire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kinspire in its N-PORT filings yet. We sweep new filings monthly.